These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29050505)

  • 1. Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25.
    Sibley MH; Rohde LA; Swanson JM; Hechtman LT; Molina BSG; Mitchell JT; Arnold LE; Caye A; Kennedy TM; Roy A; Stehli A;
    Am J Psychiatry; 2018 Feb; 175(2):140-149. PubMed ID: 29050505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Little evidence for late-onset ADHD in a longitudinal sample of women.
    Ahmad SI; Owens EB; Hinshaw SP
    J Consult Clin Psychol; 2019 Jan; 87(1):112-117. PubMed ID: 30570306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential implications of persistent, remitted, and late-onset ADHD symptoms for substance abuse in women and men: A twin study from ages 11 to 24.
    Elkins IJ; Saunders GRB; Malone SM; Wilson S; McGue M; Iacono WG
    Drug Alcohol Depend; 2020 Jul; 212():107947. PubMed ID: 32444170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
    Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
    Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood.
    Agnew-Blais JC; Polanczyk GV; Danese A; Wertz J; Moffitt TE; Arseneault L
    JAMA Psychiatry; 2016 Jul; 73(7):713-20. PubMed ID: 27192174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the childhood symptom profile of community-based individuals diagnosed with attention-deficit/hyperactivity disorder as adults.
    Taylor MJ; Larsson H; Gillberg C; Lichtenstein P; Lundström S
    J Child Psychol Psychiatry; 2019 Mar; 60(3):259-266. PubMed ID: 30338854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of DSM-5 age-of-onset criterion of attention deficit/hyperactivity disorder (ADHD) in adults: Comparison of life quality, functional impairment, and family function.
    Lin YJ; Lo KW; Yang LK; Gau SS
    Res Dev Disabil; 2015 Dec; 47():48-60. PubMed ID: 26318976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome.
    Caye A; Rocha TB; Anselmi L; Murray J; Menezes AM; Barros FC; Gonçalves H; Wehrmeister F; Jensen CM; Steinhausen HC; Swanson JM; Kieling C; Rohde LA
    JAMA Psychiatry; 2016 Jul; 73(7):705-12. PubMed ID: 27192050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    Weibel S; Menard O; Ionita A; Boumendjel M; Cabelguen C; Kraemer C; Micoulaud-Franchi JA; Bioulac S; Perroud N; Sauvaget A; Carton L; Gachet M; Lopez R
    Encephale; 2020 Feb; 46(1):30-40. PubMed ID: 31610922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
    Regan T; Tubman J
    Subst Use Misuse; 2020; 55(1):119-132. PubMed ID: 31502500
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterotypic trajectories of dimensional psychopathology across the lifespan: the case of youth-onset attention deficit/hyperactivity disorder.
    Manfro AG; Santoro M; Polanczyk GV; Gadelha A; Pan PM; Bressan RA; Brietzke E; Talarico F; Belangero S; Rohde LA; Salum GA
    J Child Psychol Psychiatry; 2019 May; 60(5):533-544. PubMed ID: 30329156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?
    Faraone SV; Biederman J; Spencer T; Mick E; Murray K; Petty C; Adamson JJ; Monuteaux MC
    Am J Psychiatry; 2006 Oct; 163(10):1720-9; quiz 1859. PubMed ID: 17012682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men.
    Moggi F; Schorno D; Soravia LM; Mohler-Kuo M; Estévez-Lamorte N; Studer J; Gmel G
    Eur Addict Res; 2020; 26(4-5):233-244. PubMed ID: 32564034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
    Todd RD; Huang H; Henderson CA
    J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric comorbidities of adults with early- and late-onset attention-deficit/hyperactivity disorder.
    Lin YJ; Yang LK; Gau SS
    Aust N Z J Psychiatry; 2016 Jun; 50(6):548-56. PubMed ID: 26460330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood.
    Meinzer MC; Lewinsohn PM; Pettit JW; Seeley JR; Gau JM; Chronis-Tuscano A; Waxmonsky JG
    Depress Anxiety; 2013 Jun; 30(6):546-53. PubMed ID: 23424020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.